Javascript must be enabled to continue!
Synthesis and Evaluation of Chalcone and its Derivatives as Potential Anticholinergic Agents
View through CrossRef
Background: Structural similarity in Chalcone and Pyrazoline brought our intention for
the analysis of such compounds. This study involved the synthesis of chalcones and their pyrazoline
derivatives and their screening as cholinesterase inhibitors. The newly synthesized compounds were
also investigated for their antioxidant potential.
</P><P>
Methods: Chalcones were synthesized by well-established methods of synthesis and their structural
elucidation was carried out by H-NMR, 13C-NMR, Mass spectrometry and FTIR. For the determination
of inhibition potency of synthesized compounds, spectrophotometric method was applied
whereas, DPPH free radical scavenging method was used to check the antioxidant ability.
</P><P>
Results: Chalcones and their pyrazoline derivatives were synthesized and characterised by 1HNMR,
13C-NMR, Mass spectrometry and FTIR. The compounds were screened for their anti-
Alzheimer activity, which exhibited that compounds 1g, 1c and 1h, 1g showed strong inhibitory
potency against acetylcholinesterase and butyrylcholinesterase, respectively. DPPH radical scavenging
method was applied to check anti-oxidant potential of synthesized compounds and results
explored that among all the synthesized compounds only compounds 1c and 1b showed strong
scavenging potential.
</P><P>
Conclusion: Chalcone and their pyrazoline derivatives were synthesized and screened for their
anti-Alzheimer and antioxidant potential. The experimental results of anti-Alzheimer activity were
compared with molecular docking studies, which showed that compounds 1g, 1c and 1h, 1g were
active against AChE and BChE, respectively. Among the synthesized compounds 1c and 1b were
found to be most potent antioxidants. These results suggest that compound 1b, 1c, 1g and 1h may
further be explored for further developments.
Title: Synthesis and Evaluation of Chalcone and its Derivatives as Potential Anticholinergic Agents
Description:
Background: Structural similarity in Chalcone and Pyrazoline brought our intention for
the analysis of such compounds.
This study involved the synthesis of chalcones and their pyrazoline
derivatives and their screening as cholinesterase inhibitors.
The newly synthesized compounds were
also investigated for their antioxidant potential.
</P><P>
Methods: Chalcones were synthesized by well-established methods of synthesis and their structural
elucidation was carried out by H-NMR, 13C-NMR, Mass spectrometry and FTIR.
For the determination
of inhibition potency of synthesized compounds, spectrophotometric method was applied
whereas, DPPH free radical scavenging method was used to check the antioxidant ability.
</P><P>
Results: Chalcones and their pyrazoline derivatives were synthesized and characterised by 1HNMR,
13C-NMR, Mass spectrometry and FTIR.
The compounds were screened for their anti-
Alzheimer activity, which exhibited that compounds 1g, 1c and 1h, 1g showed strong inhibitory
potency against acetylcholinesterase and butyrylcholinesterase, respectively.
DPPH radical scavenging
method was applied to check anti-oxidant potential of synthesized compounds and results
explored that among all the synthesized compounds only compounds 1c and 1b showed strong
scavenging potential.
</P><P>
Conclusion: Chalcone and their pyrazoline derivatives were synthesized and screened for their
anti-Alzheimer and antioxidant potential.
The experimental results of anti-Alzheimer activity were
compared with molecular docking studies, which showed that compounds 1g, 1c and 1h, 1g were
active against AChE and BChE, respectively.
Among the synthesized compounds 1c and 1b were
found to be most potent antioxidants.
These results suggest that compound 1b, 1c, 1g and 1h may
further be explored for further developments.
Related Results
The association between anticholinergic/sedative burden and physical frailty in people aging with HIV
The association between anticholinergic/sedative burden and physical frailty in people aging with HIV
Objective:
This study aimed to estimate the strength of the association between anticholinergic/sedative burden and concurrent physical frailty in people aging with HIV...
Anticholinergic burden and poor oral health are associated with frailty in geriatric patients undergoing inpatient rehabilitation: A cross‐sectional study
Anticholinergic burden and poor oral health are associated with frailty in geriatric patients undergoing inpatient rehabilitation: A cross‐sectional study
AbstractBackgroundPoor oral health is known to be associated with frailty in geriatric populations. Recent exposure to anticholinergic medications is responsible for features of po...
Anticholinergic Burden and Xerostomia in Critical Care Settings
Anticholinergic Burden and Xerostomia in Critical Care Settings
Background
Although previous studies have established the association of medications with anticholinergic adverse effects and xerostomia, anticholinergic burden and xer...
Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study
Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study
AbstractObjectivesSeveral studies have investigated that anticholinergic drugs cause cognitive impairment. However, the risk of dementia associated with anticholinergics has not be...
Anticholinergic Medication and Caries Status Predict Xerostomia under 65
Anticholinergic Medication and Caries Status Predict Xerostomia under 65
The use of anticholinergic medications is increasing in younger ages, yet information about xerostomia, the most common anticholinergic side effect, is limited. This case–control r...
Consistency between anticholinergic burden scales in the elderly with fractures v1
Consistency between anticholinergic burden scales in the elderly with fractures v1
Consistency between anticholinergic burden scales in the elderly with fractures Objective: falls and bone fractures are important causes of morbidity and mortality in the elderly....
Cognitive impact of anticholinergic and sedative burden in people with HIV
Cognitive impact of anticholinergic and sedative burden in people with HIV
Objective:
This study aims to estimate the extent to which anticholinergic and sedative burden is associated with cognitive ability and self-reported cognitive difficul...
Evaluatie van de informatiebronnen voor het bewaken van anticholinerge effecten in de farmacotherapie
Evaluatie van de informatiebronnen voor het bewaken van anticholinerge effecten in de farmacotherapie
Monitoring anticholinergic effects in pharmacotherapy: an evaluation of information sources
Objective: This study focused on information sources accessible to healthcare provider...

